GlassScriptPhysician profile
Angelle A Hogan
NPI 1477094779
$6,258.88
in general payments reported to CMS, 2019-2025
10 companies · $4,805 in 2025
The $4,805 reported for 2025 was more than what 84% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.79 · 2022: $12.05 · 2023: $469 · 2024: $878 · 2025: $4,805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,418 · Travel and Lodging: $1,531 · Education: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,417.79 |
| Travel and Lodging | $1,531.42 |
| Education | $201.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,970.02 | 2025 | Indigo System, Penumbra System, Ruby Coil |
| Medtronic, INC. | $1,364.97 | 2022-2025 | Endurant Iis, Concertotm |
| Endologix LLC | $855.36 | 2024-2025 | Torus Stent Graft System, Endocross Device, Afx2 Bifurcated Endograft System |
| W. L. Gore & Associates, INC. | $492.77 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Silk Road Medical, INC. | $285.89 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Boston Scientific Corporation | $105.17 | 2025 | Enroute Transcarotid Stent |
| Baxter Healthcare | $95.79 | 2021 | |
| Terumo Medical Corporation | $47.32 | 2023-2025 | Azur Cx Detachable, Angio-Seal |
| Vertex Pharmaceuticals Incorporated | $22.18 | 2025 | |
| Stryker Corporation | $19.41 | 2025 | Flowtriever |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelle Hogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.